標(biāo)準(zhǔn)解讀
《GB/T 26436-2025 禽白血病診斷技術(shù)》與《GB/T 26436-2010 禽白血病診斷技術(shù)》相比,在多個方面進(jìn)行了更新和改進(jìn)。具體變化包括但不限于以下幾個方面:
首先,新標(biāo)準(zhǔn)對術(shù)語和定義部分進(jìn)行了修訂,增加了新的術(shù)語以適應(yīng)近年來在禽白血病研究領(lǐng)域出現(xiàn)的新概念和技術(shù)進(jìn)展。同時,對于原有的一些定義也做了更加準(zhǔn)確的表述,確保其能夠更好地反映當(dāng)前科學(xué)共識。
其次,在樣品采集與處理環(huán)節(jié),《GB/T 26436-2025》引入了更為先進(jìn)的技術(shù)和方法,比如推薦使用自動化設(shè)備進(jìn)行血液樣本的分離純化過程,以及采用新型保存液來提高病毒RNA/DNA的穩(wěn)定性等措施,旨在提升檢測結(jié)果的準(zhǔn)確性與可靠性。
再次,關(guān)于實驗室檢測方法,《GB/T 26436-2025》不僅保留了傳統(tǒng)有效的ELISA、AGP等免疫學(xué)檢測手段,還新增了幾種基于分子生物學(xué)原理的高靈敏度快速篩查技術(shù),如實時熒光定量PCR(qPCR)、數(shù)字PCR(dPCR)等,這些新技術(shù)的應(yīng)用極大地提高了禽白血病早期發(fā)現(xiàn)的能力,并為后續(xù)防控工作提供了強有力的支持。
此外,《GB/T 26436-2025》還特別強調(diào)了生物安全防護(hù)的重要性,在整個實驗過程中都加強了對操作人員的安全教育及個人防護(hù)裝備的要求,以防止交叉污染或意外感染事件的發(fā)生。
最后,新版標(biāo)準(zhǔn)針對不同場景下的應(yīng)用需求制定了更為詳細(xì)的指導(dǎo)原則,例如如何根據(jù)農(nóng)場規(guī)模選擇合適的采樣策略、怎樣合理安排監(jiān)測頻率以實現(xiàn)成本效益最大化等內(nèi)容都被納入其中,使得該標(biāo)準(zhǔn)更具實用性和可操作性。
如需獲取更多詳盡信息,請直接參考下方經(jīng)官方授權(quán)發(fā)布的權(quán)威標(biāo)準(zhǔn)文檔。
....
查看全部
- 現(xiàn)行
- 正在執(zhí)行有效
- 2025-01-24 頒布
- 2025-08-01 實施
文檔簡介
ICS11.220
CCSB41
中華人民共和國國家標(biāo)準(zhǔn)
GB/T26436—2025
代替GB/T26436—2010
禽白血病診斷技術(shù)
Diagnostictechniquesforavianleukosis
2025?01?24發(fā)布2025?08?01實施
國家市場監(jiān)督管理總局
國家標(biāo)準(zhǔn)化管理委員會發(fā)布
GB/T26436—2025
目次
前言··························································································································Ⅲ
引言··························································································································Ⅳ
1范圍·······················································································································1
2規(guī)范性引用文件········································································································1
3術(shù)語和定義··············································································································1
4縮略語····················································································································1
5實驗室生物安全措施··································································································2
6臨床診斷·················································································································2
6.1流行病學(xué)···········································································································2
6.2臨床癥狀···········································································································2
6.3病理變化···········································································································3
6.4鑒別診斷···········································································································3
6.5臨床判定···········································································································3
7樣品采集與處理········································································································4
7.1樣品采集···········································································································4
7.2樣品處理···········································································································4
8實驗室診斷··············································································································4
8.1病毒分離和鑒定··································································································4
8.2病毒亞群的鑒定··································································································7
8.3Real?timeRT?PCR擴增ALV?J···············································································7
8.4血清學(xué)診斷········································································································7
9綜合判定·················································································································8
9.1疑似·················································································································8
9.2確診·················································································································8
附錄A(規(guī)范性)病毒分離相關(guān)溶液的配制········································································9
A.10.01mol/LPBS(pH7.4)······················································································9
A.250%甘油?PBS保存液(pH7.4)··············································································9
A.3細(xì)胞完全營養(yǎng)液和維持液······················································································9
附錄B(資料性)CEF(C/E品系)的制備··········································································10
附錄C(資料性)抗ALV單因子雞血清的制備··································································11
附錄D(規(guī)范性)p27抗原ELISA檢測相關(guān)溶液的配制·······················································12
D.1包被液············································································································12
D.2洗滌液············································································································12
Ⅰ
GB/T26436—2025
D.3樣品稀釋液······································································································12
D.4底物溶液·········································································································12
D.5終止液············································································································12
附錄E(資料性)ALV亞群鑒定程序···············································································13
E.1克隆載體和宿主菌·····························································································13
E.2病毒模板的制備································································································13
E.3囊膜蛋白env基因的擴增·····················································································13
E.4PCR產(chǎn)物的克隆·······························································································14
E.5質(zhì)粒DNA的提取和鑒定····················································································15
E.6克隆序列的測定································································································15
附錄F(資料性)Real?timeRT?PCR擴增ALV?J································································17
F.1引物和探針序列································································································17
F.2樣品采集和前處理·····························································································17
F.3核酸抽提·········································································································17
F.4擴增試劑準(zhǔn)備···································································································17
F.5加樣檢測·········································································································18
F.6反應(yīng)條件設(shè)置···································································································18
F.7熒光素設(shè)定······································································································18
F.8分析條件設(shè)定及結(jié)果判定····················································································18
附錄G(資料性)ALV?J一步法Real?timeRT?PCR檢測試劑盒的組成及使用···························19
G.1試劑盒組成······································································································19
G.2說明···············································································································19
G.3使用時的注意事項·····························································································19
附錄H(資料性)IFA法抗體檢測用ALV感染細(xì)胞的制備··················································20
參考文獻(xiàn)····················································································································21
Ⅱ
GB/T26436—2025
前言
本文件按照GB/T1.1—2020《標(biāo)準(zhǔn)化工作導(dǎo)則第1部分:標(biāo)準(zhǔn)化文件的結(jié)構(gòu)和起草規(guī)則》的規(guī)
定起草。
本文件代替GB/T26436—2010《禽白血病診斷技術(shù)》,與GB/T26436—2010相比,除結(jié)構(gòu)調(diào)整和
編輯性改動外,主要技術(shù)變化如下:
——增加了“縮略語”(見第4章);
——增加了ALV?p27抗原免疫膠體金試紙卡檢測方法(見8.1.4.3);
——更改了抗體檢測結(jié)果對確診的判定標(biāo)準(zhǔn)(見8.4.5,2010年版的4.3.2.3)。
請注意本文件的某些內(nèi)容可能涉及專利。本文件的發(fā)布機構(gòu)不承擔(dān)識別專利的責(zé)任。
本文件由中華人民共和國農(nóng)業(yè)農(nóng)村部提出。
本文件由全國動物衛(wèi)生標(biāo)準(zhǔn)化技術(shù)委員會(SAC/TC181)歸口。
本文件起草單位:山東農(nóng)業(yè)大學(xué)、中華人民共和國拱北海關(guān)技術(shù)中心、華南農(nóng)業(yè)大學(xué)、揚州大學(xué)、
中國農(nóng)業(yè)科學(xué)院哈爾濱獸醫(yī)研究所、靈羽生工(北京)醫(yī)藥科技有限公司、中國農(nóng)業(yè)大學(xué)、普萊柯生物工
程股份有限公司、中國動物疫病預(yù)防控制中心。
本文件主要起草人:趙鵬、崔治中、孫淑紅、楊素、沙才華、廖明、曹偉勝、秦愛建、錢琨、王一新、
高玉龍、陳西釗、蘇敬良、田克恭、吳清民、王傳彬。
本文件及其所代替文件的歷次版本發(fā)布情況為:
——2010年首次發(fā)布為GB/T26436—2010;
——本次為第一次修訂。
Ⅲ
GB/T26436—2025
引言
禽白血?。ˋvianleukosis,AL)是由禽白血病病毒(Avianleukosisvirus,ALV)感染引起的禽類多
種腫瘤性疾病的統(tǒng)稱,主要引起雞的惡性腫瘤和亞臨床感染,導(dǎo)致雞只生長遲緩、產(chǎn)蛋下降和免疫抑
制,是一種能夠通過種蛋垂直傳播的免疫抑制性疾病,我國將其列為三類動物疫病。
ALV屬于反轉(zhuǎn)錄病毒科正反錄病毒亞科甲型反轉(zhuǎn)錄病毒屬,根據(jù)其gp85蛋白的特性目前將
ALV分為A、B、C、D、E、F、G、H、I、J和K共11個亞群。ALV分為內(nèi)源性ALV和外源性ALV兩大
類。內(nèi)源性ALV是指整合進(jìn)宿主細(xì)胞染色體基因組因而能通過染色體垂直傳播的ALV,它可能只是
病毒基因組的不完全片段不產(chǎn)生傳染性病毒粒子,也可能是病毒全基因組因而能產(chǎn)生傳染性病毒粒
子,不過這類病毒通常致病性很低或無致病性,主要是E亞群ALV。外源性ALV是與內(nèi)源性ALV
相對應(yīng)的,指不通過宿主細(xì)胞染色體傳遞給下一代的ALV,包括A、B、C、D、J和K亞群,致病性強的
ALV均屬于外源性病毒。內(nèi)源性ALV的干擾是開展實驗室檢測,特別是進(jìn)行核酸檢測時首要排除
因素。
本病發(fā)生沒有明顯的季節(jié)性或地域性,通常因為飼養(yǎng)種源未凈化ALV的雞苗而發(fā)病,以及在育雛
期與感染雞群混養(yǎng)或者使用存在外源性ALV污染的生物制品而感染發(fā)病。
本文件診斷技術(shù)內(nèi)容包括臨床診斷、病原學(xué)診斷和血清學(xué)診斷方法。本文件的修訂參考了世界動
物衛(wèi)生組織(WOAH)《陸生動物診斷試驗和疫苗手冊》,并結(jié)合了我國相關(guān)技術(shù)研究新成果。
Ⅳ
GB/T26436—2025
禽白血病診斷技術(shù)
1范圍
本文件描述了禽白血病的臨床診斷、樣品采集與處理,以及病毒分離
溫馨提示
- 1. 本站所提供的標(biāo)準(zhǔn)文本僅供個人學(xué)習(xí)、研究之用,未經(jīng)授權(quán),嚴(yán)禁復(fù)制、發(fā)行、匯編、翻譯或網(wǎng)絡(luò)傳播等,侵權(quán)必究。
- 2. 本站所提供的標(biāo)準(zhǔn)均為PDF格式電子版文本(可閱讀打?。?,因數(shù)字商品的特殊性,一經(jīng)售出,不提供退換貨服務(wù)。
- 3. 標(biāo)準(zhǔn)文檔要求電子版與印刷版保持一致,所以下載的文檔中可能包含空白頁,非文檔質(zhì)量問題。
最新文檔
- 2026年數(shù)據(jù)庫原理與應(yīng)用考試模擬卷
- 2026年中醫(yī)藥學(xué)專家中藥藥理學(xué)研究新進(jìn)展考點題
- 上消化道腫瘤患者的護(hù)理
- 外陰損傷課件
- 2026年贛州職業(yè)技術(shù)學(xué)院單招綜合素質(zhì)筆試模擬試題含詳細(xì)答案解析
- 2026年上海杉達(dá)學(xué)院單招綜合素質(zhì)考試參考題庫含詳細(xì)答案解析
- 眼外傷的緊急處理
- 2026年牡丹江大學(xué)高職單招職業(yè)適應(yīng)性測試模擬試題及答案詳細(xì)解析
- 2026年濰坊工商職業(yè)學(xué)院高職單招職業(yè)適應(yīng)性測試備考試題及答案詳細(xì)解析
- 2026年鄭州電力高等??茖W(xué)校單招綜合素質(zhì)考試模擬試題含詳細(xì)答案解析
- 電梯維保服務(wù)質(zhì)量承諾書
- 2026云南省普洱市事業(yè)單位招聘工作人員390人重點基礎(chǔ)提升(共500題)附帶答案詳解
- 2026年輔警招聘考試試題庫100道及答案【歷年真題】
- 接線工藝要求培訓(xùn)
- 2025至2030中國稀有糖行業(yè)深度研究及發(fā)展前景投資評估分析
- 2026廣西壯族自治區(qū)公安機關(guān)人民警察特殊職位招錄考試195人參考題庫附答案
- 《畢業(yè)設(shè)計(論文)》課程教學(xué)大綱(本科)
- 2025年人口老齡化對醫(yī)療衛(wèi)生服務(wù)的影響研究報告及未來發(fā)展趨勢預(yù)測
- 核醫(yī)學(xué)科骨轉(zhuǎn)移顯像診斷指南
- 公共區(qū)域精裝修施工組織設(shè)計
- 2025-2030智慧城市大腦建設(shè)規(guī)劃與多感知系統(tǒng)融合
評論
0/150
提交評論